The beverage giant Coca-Cola has been involved in talks with Canadian cannabis producer Aurora Cannabis regarding the possible development of marijuana-infused beverages, Canada's BNN Bloomberg has revealed.
Coca-Cola has declined to comment on the possible partnership, but in a statement released by the firm it revealed that "along with many others in the beverage industry, (it is) closely watching the growth of non-psychoactive cannabidiol as an ingredient in functional wellness beverages around the world".
Cannababidol, or CBD, is a chemical found in cannabis which, despite having no psychoactive effects, has been found to have a myriad of positive health benefits in the body, from helping with nausea and inflammation to relieving some Parkinson's and dementia symptoms. Reports have alleged that Coca-Cola is considering using the substance in some form of "recovery drink".
Visit Innovation Enterprise's Big Data Analytics In Healthcare Summit in San Francisco on October 15–16, 2018
The global cannabis market is expected to be worth $146.4bn by 2025, according to Grand View Research, and if the anticipated softening of cannabis laws around the world continues, Coca-Cola will not be the only high-profile company trying to enter the industry. Since Canada legalized recreational use of the substance, Corona has invested $4bn into Canopy Growth , another Canadian Cannabis firm, and Molson Coors Brewing has already announced its intention to create cannabis-infused beverages with Hydropothecary.
Aurora has also declined to comment on the possible deal with Coca-Cola but has previously stated: "Aurora has expressed specific interest in the infused beverage space, and we intend to enter that market."